Interleukin-6 (IL-6) Blockade with Siltuximab Peri-Autologous Hematopoietic Stem Cell Transplantation (AHCT) May Reduce Symptom Burden by Altering the Cytokine Milieu in Older Patients with Multiple Myeloma (MM)